|
1
|
Liang X, Bi S, Yang W, Wang L, Cui G, Cui
F, Zhang Y, Liu J, Gong X, Chen Y, et al: Reprint of:
Epidemiological serosurvey of Hepatitis B in China - declining HBV
prevalence due to Hepatitis B vaccination. Vaccine. 31 Suppl
9:J21–J28. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marcellin P, Gane E, Buti M, Afdhal N,
Sievert W, Jacobson IM, Washington MK, Germanidis G, Flaherty JF,
Schall Aguilar R, et al: Regression of cirrhosis during treatment
with tenofovir disoproxil fumarate for chronic hepatitis B: A
5-year open-label follow-up study. Lancet. 381:468–475. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ringelhan M, Heikenwalder M and Protzer U:
Direct effects of hepatitis B virus-encoded proteins and chronic
infection in liver cancer development. Dig Dis. 31:138–151. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singh S, Fujii LL, Murad MH, Wang Z,
Asrani SK, Ehman RL, Kamath PS and Talwalkar JA: Liver stiffness is
associated with risk of decompensation, liver cancer, and death in
patients with chronic liver diseases: a systematic review and
meta-analysis. Clin Gastroenterol Hepatol. 11(1573–1584):
e1571–1572; quiz e1588-1579. 2013.
|
|
5
|
Ringelhan M, O'Connor T, Protzer U and
Heikenwalder M: The direct and indirect roles of HBV in liver
cancer: Prospective markers for HCC screening and potential
therapeutic targets. J Pathol. 235:355–367. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lau CC, Sun T, Ching AK, He M, Li JW, Wong
AM, Co NN, Chan AW, Li PS, Lung RW, et al: Viral-human chimeric
transcript predisposes risk to liver cancer development and
progression. Cancer Cell. 25:335–349. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang H, Zhang G, Wu Z, Lu B, Yuan D, Li X
and Lu Z: MicoRNA-451 is a novel tumor suppressor via targeting
c-myc in head and neck squamous cell carcinomas. J Cancer Res Ther.
11 Suppl 2:C216–C221. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun L, Jiang R, Li J, Wang B, Ma C, Lv Y
and Mu N: MicoRNA-425-5p is a potential prognostic biomarker for
cervical cancer. Ann Clin Biochem. 54:127–133. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wei X, Xiang T, Ren G, Tan C, Liu R, Xu X
and Wu Z: miR-101 is down-regulated by the hepatitis B virus ×
protein and induces aberrant DNA methylation by targeting DNA
methyltransferase 3A. Cell Signal. 25:439–446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shiu TY, Huang SM, Shih YL, Chu HC, Chang
WK and Hsieh TY: Hepatitis C virus core protein down-regulates
p21(Waf1/Cip1) and inhibits curcumin-induced apoptosis through
microRNA-345 targeting in human hepatoma cells. PLoS One.
8:e610892013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−∆∆C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ozen C, Yildiz G, Dagcan AT, Cevik D, Ors
A, Keles U, Topel H and Ozturk M: Genetics and epigenetics of liver
cancer. N Biotechnol. 30:381–384. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen WQ, Zheng RS and Zhang SW: Liver
cancer incidence and mortality in China, 2009. Chin J Cancer.
32:162–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qu C, Chen T, Fan C, Zhan Q, Wang Y, Lu J,
Lu LL, Ni Z, Huang F, Yao H, et al: Efficacy of neonatal HBV
vaccination on liver cancer and other liver diseases over 30-year
follow-up of the Qidong hepatitis B intervention study: A cluster
randomized controlled trial. PLoS Med. 11:e10017742014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sheng Y, Li J, Zou C, Wang S, Cao Y, Zhang
J, Huang A and Tang H: Downregulation of miR-101-3p by hepatitis B
virus promotes proliferation and migration of hepatocellular
carcinoma cells by targeting Rab5a. Arch Virol. 159:2397–2410.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng SQ, Li YX, Zhang Y, Li X and Tang H:
MiR-101 regulates HSV-1 replication by targeting ATP5B. Antiviral
Res. 89:219–226. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Q, Xu M, Qu Y, Li Z, Zhang Q, Cai X
and Lu L: Analysis of the differential expression of circulating
microRNAs during the progression of hepatic fibrosis in patients
with chronic hepatitis B virus infection. Mol Med Rep.
12:5647–5654. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen Q, Bae HJ, Eun JW, Kim HS, Park SJ,
Shin WC, Lee EK, Park S, Park WS, Lee JY, et al: MiR-101 functions
as a tumor suppressor by directly targeting nemo-like kinase in
liver cancer. Cancer Lett. 344:204–211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Srivastava SK, Bhardwaj A, Arora S, Tyagi
N, Singh S, Andrews J, McClellan S, Wang B and Singh AP:
MicroRNA-345 induces apoptosis in pancreatic cancer cells through
potentiation of caspase-dependent and -independent pathways. Br J
Cancer. 113:660–668. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Du Y, Kong G, You X, Zhang S, Zhang T, Gao
Y, Ye L and Zhang X: Elevation of highly up-regulated in liver
cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell
proliferation via down-regulating p18. J Biol Chem.
287:26302–26311. 2012. View Article : Google Scholar : PubMed/NCBI
|
